For Contemporary Pediatrics, Dr Bobby Lazzara discusses a study in Pediatrics that looked at what occurred in the wake of California's Senate Bill 277, which removed personal belief exemptions for vaccines.
BNT162b2 COVID vaccine effective in children amid Delta, Omicron periods
January 17th 2024Investigators of a study published in Annals of Internal Medicine concluded that the BNT162b2 COVID-19 vaccine demonstrated efficacy against the Delta and Omicron variants of COVID-19 in children and adolescents, offering new, extended follow-up period data.